Mira Hormone Monitor, Mira Android App

View CSAF Summary Successful exploitation of these vulnerabilities could allow an attacker to access unauthorized health profile information, make changes to health information, cause a denial-of-service condition, disclose session token information, and obtain control of user accounts. The following versions of Mira Hormone Monitor, Mira Android App are affected: Mira Monitor Firmware 1.7.1.47 (CVE-2026-66875, CVE-2026-66098, CVE-2026-67558, CVE-2026-67568, CVE-2026-68067, CVE-2026-66340, CVE-2026-64934, CVE-2026-66832) Mira Android App 4.5.15.4 (CVE-2026-66875, CVE-2026-66098, CVE-2026-67558, CVE-2026-67568, CVE-2026-68067, CVE-2026-66340, CVE-2026-64934, CVE-2026-66832) CVSS Vendor Equipment Vulnerabilities v3 9.8 Quanovate Tech Inc. (operating as Mira / Mira Care) Mira Hormone Monitor, Mira Android App Missing Authentication for Critical Function, Authentication Bypass by Spoofing, Use of Hard-coded Credentials, Weak Authentication, Improper Restriction of Excessive Authentication Attempts, Reliance on Untrusted Inputs in a Security Decision, Use of GET Request Method With Sensitive Query Strings Background Critical Infrastructure Sectors: Healthcare and Public Health Countrie…